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Transcription from the mouse mammary tumor virus (MMTV) promoter can be induced by progestins.The
progesterone receptor (PR) binds to a cluster of five hormone responsive elements (HREs) and activates the
promoter by synergistic interactions with the ubiquitous transcription factor, nuclear factor 1 (NF1).
Progesterone treatment of cells in culture leads to activation of the Src/Ras/Erk/Msk1 cascade. Selective
inhibition of Erk, or its target kinase Msk1, interferes with chromatin remodeling and blocks MMTV activation.
A complex of activated PR, Erk and Msk1 is recruited to promoter after 5 min of hormone treatment and
phosphorylates histone H3 at serine 10.This modification promotes the displacement of HP1γ and subsequent
chromatin remodeling. Progestin treatment leads to the recruitment of the BAF complex, which selectively
displaces histones H2A and H2B from the nucleosome containing the HREs.The acetyltransferase PCAF is
also required for induction of progesterone target genes and acetylates histone H3 at K14, an epigenetic mark,
which interacts with Brg1 and Brm, anchoring the BAF complex to chromatin. In nucleosomes assembled on
either MMTV or mouse rDNA promoter sequences, SWI/SNF displaces histones H2A and H2B from MMTV,
but not from the rDNA nucleosome.Thus, the outcome of nucleosome remodeling by purified SWI/SNF
depends on DNA sequence.The resultant H3/H4 tetramer particle is then the substrate for subsequent events
in induction.Thus, initial activation of the MMTV promoter requires activation of several kinases and PCAF
leading to phosphoacetylation of H3, and recruitment of BAF with subsequent removal of H2A/H2B.
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Introduction
The promoter of the mouse mammary tumor virus
(MMTV) provirus is a well-characterized example of
transcriptional control by steroid hormones in which the
chromatin organization plays an important role
[Richard-Foy and Hager, 1987].The provirus integrated
in the host cell chromatin is virtually silent in the absence
of hormones, but responds with rapid transcriptional
activation to the addition of either glucocorticoids or
progestins.The receptors for these hormones bind to a
cluster of HREs in the MMTV promoter and facilitate the
interaction of ubiquitous transcription factors including
Nuclear Factor 1 (NF1) [Di Croce et al., 1999] and the
octamer transcription factor, Oct1/OTF1 [Bruggemeier et
al., 1991] with their target sites located between the HREs
and the TATA box.This results in a synergistic activation
of transcription by the hormone receptors and NF1 (for
a review see [Beato et al., 1995]). How synergism
between PR and NF1 occurs is a question that has
attracted considerable attention, but the mechanism is
not simply cooperative DNA binding of the various
proteins to the MMTV promoter DNA [Bruggemeier et al.,
1990].
Chromatin organization and factor
binding
The LTR region of MMTV is organized into positioned
nucleosomes [Richard-Foy and Hager, 1987] and
hormone induction leads to the appearance of a DNase
I-hypersensitive region over the promoter chromatin [Zaret
and Yamamoto, 1984], suggesting an influence of
hormone induction on the chromatin organization of the
promoter ( Figure 1). A role for nucleosome phasing in
MMTV regulation has been postulated based on studies
with breast cancer cell lines carrying a single copy of
MMTV reporter stably integrated and on in vitro
nucleosome assembly studies [Truss et al., 1995].Though
the exact positioning of nucleosome over the MMTV
promoter has been debated [Fragoso et al., 1995], a
dominant nucleosome phase in breast cancer cells
precludes binding of NF1, but permits steroid hormone
receptors (SHRs) to recognize one properly oriented HRE
within the HRE cluster [Truss et al., 1995] ( Figure 1).
The different affinities of SHRs and NF1 for
nucleosomally-organized target sites can be reproduced
in vitro [Eisfeld et al., 1997; Pina et al., 1990a] and reflect
the different ways in which the two proteins recognize
their cognate DNA sequences [Beato and Eisfeld, 1997].
SHRs only contact a narrow region of the HRE DNA
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exposed, while NF1 embraces the complete
circumference of the helix and thus cannot interact with
target sites within nucleosomes.When both SHRs and
NF1 are added simultaneously to isolated MMTV
mononucleosomes, the receptors bind to the accessible
HREs, but NF1 is unable to recognize its target sites (
Figure 1) [Pina et al., 1990a], suggesting that additional
components are required for simultaneous factor binding
as detected in intact cells by genomic footprinting analysis
following hormone treatment [Truss et al., 1995].
Figure 1.  Schematic representation of the main cis elements in
the MMTV promoter and their occupancy in nucleosomes assembled
in vitro (upper panel) and in intact cells after hormone induction
(lower panel). The positions covered by the main population of histone
octamers are indicated by the grey ovals.The HREs, the NF1 binding
site and the TATA box are indicated.The numbers refer to the distance
in nucleotides from the transcription start site.The hormone receptor (PR)
dimers are depicted in yellow and the NF1 dimer by green circles.
When introduced in Saccharomyces cerevisiae
engineered to express GR or PR, the MMTV promoter is
organized into positioned nucleosomes, is silent in the
absence of hormone, and responds poorly to expression
of NFI or to a NFI-VP16 fusion, but can be induced by
hormone treatment [Chavez et al., 1995]. Deletion of the
HREs disrupts nucleosome positioning and makes the
promoter responsive to NFI-VP16, suggesting that the
HRE region would repress access to the NFI site by
positioning a nucleosome [Candau et al., 1996].The
nucleosomal organization of the MMTV promoter in vitro
is similar in yeast and animal cells, implying that the DNA
sequence contains conformational or topological
information which determines nucleosome positioning
[Pina et al., 1990b] and thus modulates the accessibility
of transcription factors to cis-acting elements.
Hormone induction was believed to result in a
displacement of the nucleosome over the promoter, thus
allowing free access of NF1 to its binding site and
transcriptional activation [Richard-Foy and Hager, 1987].
However, genomic footprinting of the chromosomal MMTV
promoter shows that hormone induction does not lead to
displacement, but rather to a rearrangement of
nucleosomes, which is necessary for simultaneous
binding of receptors, NFI and OTF1 [Truss et al., 1995].
Thus, contrary to the situation in the test tube, the
presence of a positioned nucleosome in vivo is not an
obstacle, but rather a prerequisite for simultaneous factor
binding and optimal induction of the MMTV promoter (
Figure 1) [Truss et al., 1995].This is strongly supported
by the observation that nucleosome depletion in yeast,
while enhancing the accessibility of the MMTV promoter
for hormone receptors and NF1, eliminates the functional
synergism between these two factors [Chavez and Beato,
1997]. Moreover, in a cell-free system, synergistic binding
of receptors and NF1 to the MMTV promoters depends
on its previous assembly into minichromosomes with
positioned nucleosomes and on preincubation in the
presence of ATP [Di Croce et al., 1999].
FRET experiments and footprints
Fluorescence photobleaching experiments in living cells
containing a cluster of 200 MMTV promoters in tandem
have provided direct evidence that the hormone-occupied
GR undergoes rapid exchange between chromatin and
the nucleoplasmic compartment with a half-life of less
than a minute [McNally et al., 2000].This rapid exchange
has also been reported for the ERα [Stenoien et al.,
2001a; Stenoien et al., 2001b]. In agreement with the
difficulties in visualizing a footprint of GR on the MMTV
promoter in vivo, this has led to the formulation of a
“hit-and-run” model of receptor action [Rigaud et al.,
1991]. However, following dexamethasone treatment of
hepatic cells, such footprints have been reported on the
GREs of the tyrosine aminotransferase enhancer [Becker
et al., 1986; Espinas et al., 1994]. Similarly, after progestin
addition to breast cancer cells, DNase I and DMS
footprints are observed on a single copy chromosomal
MMTV promoter [Truss et al., 1995]. Moreover, following
incubation of MMTV minichromosomes with purified PR
in Drosophila embryo extracts, clear DNase I footprints
are detected over the HREs [Di Croce et al., 1999].These
results demonstrate that a significant fraction of target
promoters must be occupied by the receptors during the
time of treatment with the footprinting agents, DMS or
DNase I. How these findings can be reconciled with the
very rapid exchange of GR-GFP observed in vivo remains
to be elucidated. One possibility is that the majority of the
GR binding events observed in the MMTV cluster in vivo
are non-productive and do not lead to stable complexes
containing receptors and NF1. Non-productive does not
imply irrelevant. Possibly, many of these weak interactions
are needed to form a stable complex of PR and NF1.
Indeed, in the absence of NF1, it is exceedingly difficult
to generate a receptor footprint on MMTV chromatin in
vitro.This can only be achieved after addition of very high
concentrations of receptor that push the equilibrium to
the DNA bound state [Di Croce et al., 1999].
Nevertheless, even in the absence of NF1, receptor
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activate chromatin transcription to some extent, indicating
that an interaction is taking place.That this short-lived
interaction could correspond to the rapid exchange
observed in vivo is suggested by the observation that
after hormone induction only a small proportion of the
MMTV clusters exhibit the phenomenon of chromatin
decondensation, indicative of active transcription [Muller
et al., 2001].
Hormone-dependent chromatin
remodeling
Role of histone H1
The nature of the hormone-induced nucleosomal change
that permits simultaneous binding of transcription factors
to the MMTV promoter remains obscure. Depletion of
histone H1 from the MMTV promoter could be a possibility
[Bresnick et al., 1992] and a role for histone H1
phosphorylation in modulating MMTV activation has been
postulated [Lee and Archer, 1998]. However, the MMTV
promoter is regulated in budding yeast, which lacks linker
histones [Chavez et al., 1995], and also in
minichromosomes assembled in the absence of histone
H1 [Di Croce et al., 1999]. Incorporation of H1 into MMTV
minichromosomes increases nucleosome spacing and
reduces access of general transcription factors to the
promoter, thus inhibiting basal transcription [Koop et al.,
2003]. However, transcription activation by PR and NF1
is enhanced in H1 containing minichromosomes [Koop
et al., 2003].This unexpected effect is due to a more
homogeneous positioning of nucleosomes in the presence
of H1 [Vicent et al., 2002] and, as a consequence, a better
binding of PR [Koop et al., 2003;Vicent et al., 2002] and
a higher proportion of promoters participating in
transcription [Koop et al., 2003]. Moreover, in the
presence of bound PR in an extract from Drosophila
embryos, H1 is phosphorylated and subsequently
removed from the promoter upon transcription initiation
[Koop et al., 2003].
Histone acetylation
Additional possibilities for chromatin remodeling are
recruitment by the receptors of chromatin remodeling
activities, either ATP-dependent, such as the SWI/SNF
complex [Cote et al., 1994], or ATP-independent, such
as histone acetyltransferases (HATs) [Lee et al., 1993].
This latter possibility has received considerable attention
following the discovery that several steroid receptor
coactivators exhibit HAT activity, including members of
the SRC-1 family, P/CAF and p300/CBP [Brown et al.,
2000].
The role of histone acetylation in hormone induction of
the MMTV promoter in not clear. High doses of histone
deacetylase inhibitors, butyrate or TSA, lead to intense
hyperacetylation of core histones and inhibit hormone
induction [Bartsch et al., 1996; Bresnick et al., 1990]
without altering nucleosome positioning [Bresnick et al.,
1991]. However, low doses of the inhibitors activate the
MMTV promoter in the absence of hormone and generate
a DNAse I-hypersensitive site similar to that observed
following hormone treatment [Bartsch et al., 1996].
Derepressing concentrations of the inhibitors of histone
deacetylases enhance hormone-activated transcription,
and thus the extent of hormonal induction is not affected
[Bartsch et al., 1996]. Similar results are obtained with
these inhibitors in the cell-free transcription assay with
MMTV minichromosomes, suggesting that
inhibitor-sensitive acetylation is not involved in mediating
the synergism between receptors and NF1. More recently,
a role for histone deacetylase 1 (HDAC1) has been
proposed for MMTV activation [Qiu et al., 2006]. HDAC1,
generally considered as a corepressor, acts as a
coactivator of the glucocorticoid receptor (GR) and its
histone deacetylase activity is regulated by a
p300-dependent acetylation [Qiu et al., 2006].The
mechanism of this effect remains unclear.
ATP-dependent remodeling
The SWI/SNF complex, or other ATP-dependent
chromatin remodeling factors, could destabilize the
interaction between the DNA double helix and the histone
octamer and thus facilitate access to otherwise masked
cis elements. Hormone-induced chromatin remodeling
might also facilitate the assembly of the transcription
initiation complex (TIC) on the TATA box, and/or
contribute to efficient transcription elongation through
downstream nucleosomes.
There is evidence for a requirement of the SWI/SNF
complex in glucocorticoid gene regulation in yeast
[Yoshinaga et al., 1992] and in animal cells [Muchardt
and Yaniv, 1993], and hSWI/SNF seems to be required
for chromatin remodeling initiated by glucocorticoids
[Fryer and Archer, 1998].The situation appears to be
different for progestins, which act through the same HREs
of the MMTV promoter [Fryer and Archer, 1998].We have
reproduced the synergism between SHR and NF1 in a
cell-free system driven by MMTV minichromosomes
assembled in extracts from Drosophila embryos [Di Croce
et al., 1999].These minichromosomes exhibit
nucleosomes positioned in the same way as in cultured
cells and the NF1 site in the promoter is not accessible
[Venditti et al., 1998]. Addition of hormone-activated GR
or PR leads to ATP-dependent remodeling of these
minichromosomes, as demonstrated by topoisomer
analysis [Di Croce et al., 1999], and to simultaneous
binding of receptors and NF1.This activity can be partly
reproduced with purified MMTV minichromosomes with
recombinant dISWI, but not with purified dCHRAC or
ySWI/SNF complex [Di Croce et al., 1999]. Moreover,
incubation of the minichromosomes in the Drosophila
extract in the presence of receptors and NF1 leads to
recruitment of dISWI, and dNURF301, two subunits of
the NURF complex [Gdula et al., 1998].Thus, in the
Drosophila embryo extract, PR recruits NURF to the
MMTV promoter chromatin, and NURF remodels the
minichromosomes in an ATP-dependent fashion.
In mammalian cells with a single MMTV promoter
integrated in chromatin we have recently found the
hormone-induced recruitment of both Brg1- and
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2006b;Vicent et al., 2004]. Moreover, in experiments with
MMTV mononucleosomes assembled in vitro, PR is able
to recruit purified yeast Swi/Snf to the promoter, where it
catalyzes the ATP-dependent displacement of H2A/H2B
dimers [Vicent et al., 2004].Though we cannot formally
exclude the possibility of a replacement of the H2A/H2B
dimers by dimers containing histone variants, our results
strongly suggest that the activated MMTV nucleosome
with bound SHRs and NF1 is a H3/H4 tetramer particle.
This assumption is further supported by our previous
findings showing that MMTV promoter sequences
assembled in vitro on H3/H4 tetramers, adopt similar
positions as on a histone octamer, but in contrast with
sequences assembled on the octamer, are able to bind
SHRs and NF1 [Spangenberg et al., 1998].
There are two human SWI/SNF-like complexes and both
contain ATPase subunits similar to yeast Swi2/Snf2,
hBRM (human Brahma) or BRG1 (Brahma-Related Gene
1), as well as a series of other subunits, some of which
differ in various cell types [Wang, 2003].The hSWI/SNF-α
complex, also called BAF (BRG1/hBRM-associated
factor), contains either hBRM or BRG1 as the central
ATPase subunit and is an orthologue of the yeast
SWI/SNF.The hSWI/SNF-β complex, also called PBAF
(Polybromo-associated BAF), contains only hBRM and
is an orthologue to the yeast RSC complex [Mohrmann
and Verrijzer, 2005].The BAF and PBAF complexes
share many subunits, but also contain subtype-specific
subunits: BAF250 and hBRM are only found in BAF,
whereas BAF180 and BAF 200 are only found in PBAF
[Mohrmann and Verrijzer, 2005;Yan et al., 2005].
In breast cancer cells that contain BAF and PBAF, we
have recently found that BAF is essential during the
activation of MMTV and other endogenous
progesterone-induced genes. BAF is recruited via an
interaction between PR and the BAF57 subunit of the
complex and is anchored by H3K14ac, generated by
PCAF, suggesting a mechanism for the cooperation
between two types of chromatin remodeling activities.
The recruited BAF catalyzes the ATP-dependent
displacement of histones H2A/H2B required for NF1 to
gain access to the promoter site.Thus, synergism
between the two transcription factors PR and NF1 is
mediated by the cooperation between two
chromatin-remodeling machines, BAF and PCAF [Vicent
et al., 2009].
Link between protein kinases and transcriptional
control
In addition to their transcriptional effect, steroid hormones
also crosstalk to kinase signaling pathways, and this
crosstalk is essential for the proliferative response of
breast cancer cells to estrogens [Migliaccio et al., 1996]
and progesterone [Migliaccio et al., 1998].
Figure 2.  Hypothetical model for the initial steps of MMTV promoter
induction. Progestins bind to cytoplasmic PR/ER complexes, and
activate the Src/Ras/Erk pathway, leading to nuclear accumulation of
activated Erk. Most of PR is nuclear and complexed to chaperones (Hsps).
Upon binding of progestins, PR homodimers dissociate from chaperones
and a fraction of PR is phosphorylated by pErk, which also phosphorylates
Msk1. A “PR -activated complex” composed of pPR/pErk/pMsk1 is formed.
What could be the connection between the rapid hormonal
activation of cytoplasmic signaling cascades and the
events taking place at the MMTV promoter? We have
investigated the function of Erk activation by
progesterone, which is mediated via an interaction
between PR and ERα (Figure 2 and [Ballare et al., 2003]).
We observed that progestin activation of the MMTV
promoter can be blocked by inhibiting Erk activation either
with antiestrogens, with small molecular inhibitors (PD
98059), with dominant negative kinase mutant, or with
RNAi against Erk [Vicent et al., 2006a]. As Erk
phosphorylated PR at ser294 in response to
progesterone, it was possible that the transcriptional
inhibition of MMTV induction was due to a lack of PR
phosphorylation. However, a similar inhibition of MMTV
induction was observed when the activation of Msk1 was
prevented by small molecular inhibitors (H89), a dominant
negative mutant of Msk, or down-regulation of Msk1 with
an specific RNAi [Vicent et al., 2006a]. Unexpectedly,
after 5 minutes of hormone treatment, we detected a
ternary complex of phosphorylated PR and activated Erk
and Msk1 ( Figure 2), which is selectively recruited to the
MMTV promoter nucleosome containing the HREs (
Figure 3) [Vicent et al., 2006a]. Concomitant with the
recruitment of the ternary complex, histone H3 becomes
phosphorylated at serine 10 and acetylated at lysine 14,
only on the nucleosome containing the HREs and not on
adjacent nucleosomes ( Figure 3) [Vicent et al., 2006a].
Blocking H3 phosphoacetylation precludes displacement
of a repressive complex containing HP1γ and recruitment
of BAF, preventing H2A/H2B displacement and promoter
activation.
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in chromatin. Upper Panel: (1) An HP1γ-containing complex is bound
to the promoter in the absence of hormone; (2) PR-activated complex
binds BAF, but not PBAF; (3) PR-activated complex is recruited to the
nucleosome B upon hormone induction, followed by H3
phosphoacetylation.The repressive complex is displaced from the
promoter; (4) Recruitment of the BAF complex to the nucleosome B is
stabilized by PCAF-dependent H3K14 acetylation, enabling
ATP-dependent H2A/H2B displacement (and/or histone variants
incorporation); (5) This metastable opening facilitates NF1 binding,
generating a stable platform for the assembly of further PR molecules,
BAF, coactivators and the basal transcriptional machinery, including RNA
polymerase II. Lower Panel:T47D-MTVL cells were untreated (0) or
treated for 5 min with 10 nM R-5020 and subjected to ChIP assays with
the indicated specific antibodies. A schematic representation of the ChIPs
described in (Vicent et al., 2006a) and (Vicent et al., 2009) is shown.
Microarray analysis of the progesterone response in
breast cancer cells (Ballare et al., manuscript in
preparation), showed that about 25% of the
hormonally-regulated genes are sensitive to the inhibition
of Erk activation.This shows that the behavior of the
MMTV promoter does not represent a rare exception, but
also suggests that other signaling pathways are involved
in mediating progesterone action.We know that the
PI3K/Akt pathway is involved in the regulation of stromal
cell proliferation in the endometrium [Vallejo et al., 2005],
and also in the proliferative response of breast cancer
cells to estrogens [Castoria et al., 2001].There is also
evidence that the cAMP/PKA pathway is implicated in
estrogen action ([Aronica et al., 1994; Cho and
Katzenellenbogen, 1993]), and that the JAK/STAT5 plays
an important role in glucocorticoid and progesterone
effects in mammary gland ([Buser et al., 2007; Stocklin
et al., 1996; Stoecklin et al., 1997]). It remains to be
established whether the crosstalk of the SHR with these
different pathways acts merely by regulating the
phosphorylation of key transcription factors and
coregulators, or whether, as in the case of the Erk
pathway, modifications of structural components of the
chromatin also play an important role.
Conclusions
The results summarized in this review contribute to a
better understanding of the molecular mechanisms of
promoter activation by progesterone. During activation
of the MMTV promoter, the chromatin constitutes a key
component essential for regulation of transcription by
allowing synergism between the nuclear receptors and
NF-1, causing full activation of the promoter.
The linker histone H1, known as a repressive component
of chromatin needed for condensation, increases MMTV
transcription by improving the positioning of nucleosomes.
PR interacts with an exposed HRE on the surface of a
nucleosome and initiates chromatin remodeling as a
prerequisite for the subsequent steps of gene activation.
The nucleosomal DNA sequence, as part of chromatin,
contains the information required to direct the outcome
of the subsequent remodeling event.The SWI/SNF
complex, depending on the DNA sequence, can displace
histones H2A and H2B or slide the nucleosome toward
one end of the DNA fragment.Thus, the “final outcome”
in each case is completely different, depending on
structural features of the underlying DNA, which confer
the differential response to SWI/SNF action and should
be further developed.
The results with the MMTV promoter underline the
significance of incorporating a precise knowledge of the
structure of native DNA sequences in chromatin. Evidence
for the positive contributions of chromatin structure and
dynamics to the process of gene regulation continues to
accumulate at an increasing pace. A classical example
is a situation in which a positioned nucleosome brings in
close proximity cis-regulatory elements located some 200
bp apart and in this way facilitates the interaction between
DNA-bound factors.There are several examples of this
type of regulation (for a recent report see [Zhao et al.,
2001]), and one case involves an interaction of the
estrogen receptor with the transcription factor NF1 [Schild
et al., 1993].
A particularly illustrative example of the significance of
chromatin is the regulation of the Human
Immunodeficiency Virus type 1 (HIV-1), the etiologic agent
of AIDS. Recent advances have indicated that HIV-1
encoded proteins interact with chromatin-remodeling
complexes and histone-modifying enzymes, implying that
chromatin remodeling plays an important role in the HIV-1
life cycle [Henderson et al., 2004; Mahmoudi et al., 2006].
Nucleosomes are positioned on the HIV-1 LTR and act
as barriers to transcription. Following cellular activation,
these nucleosomes are modified and repositioned,
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Kharroubi and Martin, 1996;Verdin et al., 1993].
Another example where chromatin has been shown to
be essential is the gene regulation of the rat albumin gene
enhancer. In its active state, in liver nuclei, the enhancer
is organized into a nuclease-accessible array of three
positioned nucleosome-like particles N1, N2, and N3,
with bound transcription factors [McPherson et al., 1993].
The N1 nucleosome-like particle at the albumin enhancer
is positioned over the FoxA binding sites and is DNase
I-hypersensitive in hepatic cells. In contrast, in non-liver
tissues, where the FoxA sites are not occupied,
nucleosome-like particles are not precisely positioned
over the enhancer, and the enhancer is not hypersensitive
[McPherson et al., 1993]. It has been observed that FoxA
and GATA-4 bound their sites in compacted chromatin
and opened the local nucleosomal domain in the absence
of ATP-dependent enzymes [Cirillo et al., 2002].
These are just a few examples of the intricacies that the
chromatin organization of promoters and regulatory
regions impose on gene regulation.This complexity is
partly due to the fact that one of the key events during
cell differentiation in complex organisms is the progressive
chromatin-mediated silencing of genes that are not
required in a particular cell lineage and the proper
chromatin organization of those genes that will be needed
at some later stage of differentiation or in response to
external signals. Understanding this differential chromatin
organization of particular genome regions is the main
challenge for epigenetic research in the coming years.
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